Key financial indicators
Overview of key financial indicators in 1-9 2024
| Sales (in EURm) | 1-9 2024 | 1-9 2023 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 573.7 | 527.0 | 8.9% |
| Sales revenues of Podravka Group | 569.3 | 525.1 | 8.4% |
| Sales revenues of Food | 438.9 | 406.9 | 7.9% |
| Sales revenues of Pharma | 130.4 | 118.2 | 10.3% |
| Podravka Group's profitability (in EURm) | 1-9 2024 | 1-9 2023 | % change |
| Group's gross profit | 221.3 | 183.4 | 20.6% |
| Group's gross profit margin | 38.9% | 34.9% | +394 bb |
| Group's EBITDA | 98.2 | 72.5 | 35.5% |
| Group's EBITDA margin | 17.2% | 13.8% | +344 bb |
| Group's EBIT | 72.8 | 48.6 | 49.7% |
| Group's EBIT margin | 12.8% | 9.3% | +352 bb |
| Group's net profit after MI | 60.2 | 58.3 | 3.1% |
| Group's net profit margin after MI | 10.6% | 11.1% | -54 bb |
| Podravka Group's balance sheet (in EURm) | 9/30/2024 | 12/31/2023 | % change |
| Total assets | 809.7 | 778.1 | 4.1% |
| Shareholders' equity | 599.2 | 564.4 | 6.2% |
| Minority interests | 11.0 | 10.6 | 2.9% |
| Cash and cash equivalents | 21.2 | 42.5 | -50.2% |
| Financial debt | 58.5 | 57.4 | 1.9% |
| Net debt | 37.4 | 14.9 | 150.6% |
| Podravka Group's cash flow (in EURm) | 1-9 2024 | 1-9 2023 | % change |
| Net cash flow from operating activities | 52.2 | 73.6 | -29.1% |
| Capital expenditures | (58.1) | (46.9) | 23.7% |
| Depreciation and amortization | 25.3 | 23.8 | 5.9% |
| Free cash flow | (5.9) | 26.7 | -121.9% |
| Podravka Group's ratios and indicators | 9/30/2024 | 12/31/2023 | % change |
| Employee number at the end of period (in units) | 6,345 | 6,163 | 3.0% |
| P&L interest expense (in EURm) | 0.85 | 0.68 | 23.9% |
| Sales revenues / Number of employees (in EUR000) | 119.5 | 115.8 | 3.1% |
| Net profit after MI / Sales revenues (in EUR000) | 10.7 | 10.8 | -0.2% |
| Return on average assets | 6.2% | 6.4% | -14 bb |
| Return on average capital | 8.4% | 8.8% | -40 bb |
| Return on average invested capital | 11.0% | 8.3% | +274 bb |
| Total shareholders' equity / Total assets | 75.4% | 73.9% | -147 bb |
| EBIT / P&L interest expense | 98.3 | 87.3 | 12.6% |
| Net debt / EBITDA | 0.3 | 0.2 | 97.1% |
| Sales (in EURm) | 1-6 2024 | 1-6 2023 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 381.5 | 347.4 | 9.8% |
| Sales revenues of Podravka Group | 380.4 | 346.3 | 9.9% |
| Sales revenues of Food | 290.5 | 265.2 | 9.6% |
| Sales revenues of Pharma | 89.8 | 81.0 | 10.8% |
| Podravka Group's profitability (in EURm) | 1-6 2024 | 1-6 2023 | % change |
| Group's gross profit | 148.9 | 122.2 | 21.8% |
| Group's gross profit margin | 39.1% | 35.3% | +384 bb |
| Group's EBITDA | 65.8 | 48.3 | 36.2% |
| Group's EBITDA margin | 17.3% | 14.0% | +334 bb |
| Group's EBIT | 49.1 | 32.4 | 51.4% |
| Group's EBIT margin | 12.9% | 9.4% | +354 bb |
| Group's net profit after MI | 40.2 | 45.2 | -11.0% |
| Group's net profit margin after MI | 10.6% | 13.1% | -247 bb |
| Podravka Group's balance sheet (in EURm) | 6/30/2024 | 12/31/2023 | % change |
| Total assets | 818.1 | 778.1 | 5.1% |
| Shareholders' equity | 579.7 | 564.4 | 2.7% |
| Minority interests | 10.7 | 10.6 | 0.1% |
| Cash and cash equivalents | 49.1 | 42.5 | 15.4% |
| Financial debt | 59.9 | 57.4 | 4.3% |
| Net debt | 10.8 | 14.9 | -27.3% |
| Podravka Group's cash flow (in EURm) | 1-6 2024 | 1-6 2023 | % change |
| Net cash flow from operating activities | 45.3 | 45.1 | 0.5% |
| Capital expenditures | (39.8) | (28.7) | 38.8% |
| Depreciation and amortization | 16.7 | 15.9 | 5.2% |
| Free cash flow | 5.6 | 16.5 | -66.2% |
| Podravka Group's ratios and indicators | 6/30/2024 | 12/31/2023 | % change |
| Employee number at the end of period (in units) | 6,171 | 6,163 | 0.1% |
| P&L interest expense (in EURm) | 0.75 | 0.68 | 10.1% |
| Sales revenues / Number of employees (in EUR000) | 121.2 | 115.8 | 4.6% |
| Net profit after MI / Sales revenues (in EUR000) | 10.0 | 10.8 | -7.6% |
| Return on average assets | 6.2% | 6.4% | -21 bb |
| Return on average capital | 8.5% | 8.8% | -31 bb |
| Return on average invested capital | 10.5% | 8.3% | +216 bb |
| Total shareholders' equity / Total assets | 72.2% | 73.9% | +173 bb |
| EBIT / P&L interest expense | 100.8 | 87.3 | 15.5% |
| Net debt / EBITDA | 0.1 | 0.2 | -38.7% |
| Sales (in EURm) | 1-3 2024 | 1-3 2023 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 192.2 | 176.4 | 9.0% |
| Sales revenues of Podravka Group | 191.8 | 175.9 | 9.1% |
| Sales revenues of Food | 146.5 | 131.7 | 11.3% |
| Sales revenues of Pharma | 45.3 | 44.2 | 2.5% |
| Podravka Group's profitability (in EURm) | 1-3 2024 | 1-3 2023 | % change |
| Group's gross profit | 76.6 | 62.5 | 22.5% |
| Group's gross profit margin | 39.9% | 35.6% | +437 bb |
| Group's EBITDA | 37.9 | 27.3 | 38.8% |
| Group's EBITDA margin | 19.7% | 15.5% | +423 bb |
| Group's EBIT | 29.5 | 19.4 | 51.9% |
| Group's EBIT margin | 15.4% | 11.0% | +434 bb |
| Group's net profit after MI | 23.5 | 15.7 | 49.7% |
| Group's net profit margin after MI | 12.2% | 8.9% | +332 bb |
| Podravka Group's balance sheet (in EURm) | 3/31/2024 | 12/31/2023 | % change |
| Total assets | 810.7 | 778.1 | 4.2% |
| Shareholders' equity | 586.2 | 564.4 | 3.9% |
| Minority interests | 10.3 | 10.6 | -3.1% |
| Cash and cash equivalents | 54.0 | 42.5 | 27.0% |
| Financial debt | 61.9 | 57.4 | 7.8% |
| Net debt | 7.9 | 14.9 | -46.8% |
| Podravka Group's cash flow (in EURm) | 1-3 2024 | 1-3 2023 | % change |
| Net cash flow from operating activities | 26.2 | 30.9 | -15.3% |
| Capital expenditures | (19.1) | (11.8) | 62.3% |
| Depreciation and amortization | 8.4 | 7.9 | 6.2% |
| Free cash flow | 7.1 | 19.2 | -63.0% |
| Podravka Group's ratios and indicators | 3/31/2024 | 12/31/2023 | % change |
| Employee number at the end of period (in units) | 6,171 | 6,163 | 0.1% |
| P&L interest expense (in EURm) | 0.70 | 0.68 | 2.6% |
| Sales revenues / Number of employees (in EUR000) | 118.3 | 115.8 | 2.1% |
| Net profit after MI / Sales revenues (in EUR000) | 12.0 | 10.8 | 11.6% |
| Return on average assets | 6.2% | 6.4% | -23 bb |
| Return on average capital | 8.4% | 8.8% | -41 bb |
| Return on average invested capital | 9.6% | 8.3% | +127 bb |
| Total shareholders' equity / Total assets | 73.6% | 73.9% | +32 bb |
| EBIT / P&L interest expense | 99.2 | 87.3 | 13.7% |
| Net debt / EBITDA | 0.1 | 0.2 | -52.8% |
| Sales (in EURm) | 1-12 2023 | 1-12 2022 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 717.0 | 684.2 | 4.8% |
| Sales revenues of Podravka Group | 713.8 | 667.2 | 7.0% |
| Sales revenues of Food | 553.6 | 522.2 | 6.0% |
| Sales revenues of Pharma | 160.2 | 145.0 | 10.5% |
| Podravka Group's profitability (in EURm) | 1-12 2023 | 1-12 2022 | % change |
| Group's gross profit | 248.7 | 236.7 | 5.1% |
| Group's gross profit margin | 34.8% | 35.5% | -64 bb |
| Group's EBITDA | 91.9 | 93.9 | -2.0% |
| Group's EBITDA margin | 12.9% | 14.1% | -119 bb |
| Group's EBIT | 59.3 | 62.5 | -5.2% |
| Group's EBIT margin | 8.3% | 9.4% | -107 bb |
| Group's net profit after MI | 66.4 | 49.1 | 35.3% |
| Group's net profit margin after MI | 9.3% | 7.4% | +194 bb |
| Podravka Group's balance sheet (in EURm) | 12/31/2023 | 12/31/2022 | % change |
| Total assets | 778.1 | 736.2 | 5.7% |
| Shareholders' equity | 564.4 | 519.2 | 8.7% |
| Minority interests | 10.6 | 9.4 | 12.9% |
| Cash and cash equivalents | 42.5 | 21.9 | 94.1% |
| Financial debt | 57.4 | 84.0 | -31.6% |
| Net debt | 14.9 | 62.1 | -76.0% |
| Podravka Group's cash flow (in EURm) | 1-12 2023 | 1-12 2022 | % change |
| Net cash flow from operating activities | 115.4 | 75.0 | 53.8% |
| Capital expenditures | (73.8) | (52.7) | 40.1% |
| Depreciation and amortization | 31.8 | 30.4 | 4.8% |
| Free cash flow | 41.6 | 22.4 | 86.0% |
| Podravka Group's ratios and indicators | 12/31/2023 | 12/31/2022 | % change |
| Employee number at the end of period (in units) | 6,163 | 6,299 | -2.2% |
| P&L interest expense (in EURm) | 0.68 | 0.72 | -5.3% |
| Sales revenues / Number of employees (in EUR000) | 115.8 | 105.9 | 9.4% |
| Net profit after MI / Sales revenues (in EUR000) | 10.8 | 7.8 | 38.3% |
| Return on average assets | 6.4% | 6.1% | +29 bb |
| Return on average capital | 8.8% | 8.3% | +46 bb |
| Return on average invested capital | 8.3% | 7.6% | +69 bb |
| Total shareholders' equity / Total assets | 73.9% | 71.8% | -210 bb |
| EBIT / P&L interest expense | 87.3 | 73.3 | 19.1% |
| Net debt / EBITDA | 0.2 | 0.7 | -78.2% |
| Sales (in EURm) | 1-9 2023 | 1-9 2022 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 527.0 | 496.6 | 6.1% |
| Sales revenues of Podravka Group | 525.1 | 492.7 | 6.6% |
| Sales revenues of Food | 406.9 | 388.3 | 4.8% |
| Sales revenues of Pharma | 118.2 | 104.4 | 13.3% |
| Podravka Group's profitability (in EURm) | 1-9 2023 | 1-9 2022 | % change |
| Group's gross profit | 183.4 | 175.4 | 4.6% |
| Group's gross profit margin | 34.9% | 35.6% | -67 bb |
| Group's EBITDA | 72.5 | 69.0 | 5.0% |
| Group's EBITDA margin | 13.8% | 14.0% | -21 bb |
| Group's EBIT | 48.6 | 45.8 | 6.2% |
| Group's EBIT margin | 9.3% | 9.3% | -3 bb |
| Group's net profit after MI | 58.3 | 35.7 | 63.4% |
| Group's net profit margin after MI | 11.1% | 7.2% | +386 bb |
| Podravka Group's balance sheet (in EURm) | 30.9.2023 | 31.12.2022 | % change |
| Total assets | 751.9 | 736.2 | 2.1% |
| Shareholders' equity | 555.9 | 519.2 | 7.1% |
| Minority interests | 10.3 | 9.4 | 9.3% |
| Cash and cash equivalents | 28.5 | 21.9 | 30.0% |
| Financial debt | 55.0 | 84.0 | -34.5% |
| Net debt | 26.5 | 62.1 | -57.3% |
| Podravka Group's cash flow (in EURm) | 1-9 2023 | 1-9 2022 | % change |
| Net cash flow from operating activities | 73.6 | 69.0 | 6.8% |
| Capital expenditures | (46.9) | (38.9) | 20.7% |
| Depreciation and amortization | 23.8 | 22.7 | 5.1% |
| Free cash flow | 26.7 | 30.1 | -11.2% |
| Podravka Group's ratios and indicators | 30.9.2023 | 31.12.2022 | % change |
| Employee number at the end of period (in units) | 6,198 | 6,299 | -1.6% |
| P&L interest expense (in EURm) | 0.71 | 0.72 | -2.0% |
| Sales revenues / Number of employees (in EUR000) | 112.9 | 105.9 | 6.6% |
| Net profit after MI / Sales revenues (in EUR000) | 11.6 | 7.8 | 48.5% |
| Return on average assets | 6.0% | 6.0% | +9 bb |
| Return on average capital | 8.2% | 8.1% | +11 bb |
| Return on average invested capital | 7.8% | 7.7% | +10 bb |
| Total shareholders' equity / Total assets | 75.3% | 71.8% | -351 bb |
| EBIT / P&L interest expense | 79.7 | 73.3 | 8.8% |
| Net debt / EBITDA | 0.3 | 0.7 | -59.5% |
| Sales (in EURm) | 1-6 2023 | 1-6 2022 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 347.4 | 324.4 | 7.1% |
| Sales revenues of Podravka Group | 346.3 | 320.7 | 8.0% |
| Sales revenues of Food | 265.2 | 254.0 | 4.4% |
| Sales revenues of Pharma | 81.0 | 66.7 | 21.6% |
| Podravka Group's profitability (in EURm) | 1-6 2023 | 1-6 2022 | % change |
| Group's gross profit | 122.2 | 116.9 | 4.5% |
| Group's gross profit margin | 35.3% | 36.5% | -117 bp |
| Group's EBITDA | 48.3 | 48.5 | -0.3% |
| Group's EBITDA margin | 14.0% | 15.1% | -116 bp |
| Group's EBIT | 32.4 | 33.5 | -3.2% |
| Group's EBIT margin | 9.4% | 10.5% | -108 bp |
| Group's net profit after MI | 45.2 | 26.3 | 71.8% |
| Group's net profit margin after MI | 13.1% | 8.2% | +485 bp |
| Podravka Group's balance sheet (in EURm) | 30.6.2023 | 31.12.2022 | % change |
| Total assets | 767.0 | 736.2 | 4.2% |
| Shareholders' equity | 543.8 | 519.2 | 4.7% |
| Minority interests | 10.0 | 9.4 | 6.6% |
| Cash and cash equivalents | 50.7 | 21.9 | 131.4% |
| Financial debt | 70.6 | 84.0 | -16.0% |
| Net debt | 19.9 | 62.1 | -68.0% |
| Podravka Group's cash flow (in EURm) | 1-6 2023 | 1-6 2022 | % change |
| Net cash flow from operating activities | 45.1 | 66.8 | -32.4% |
| Capital expenditures | (28.7) | (27.0) | 5.9% |
| Depreciation and amortization | 15.9 | 15.0 | 6.2% |
| Free cash flow | 16.5 | 39.7 | -58.6% |
| Podravka Group's ratios and indicators | 30.6.2023 | 31.12.2022 | % change |
| Employee number at the end of period (in units) | 6,267 | 6,299 | -0.5% |
| P&L interest expense (in EURm) | 0.66 | 0.72 | -9.1% |
| Sales revenues / Number of employees (in EUR000) | 110.5 | 105.9 | 4.4% |
| Net profit after MI / Sales revenues (in EUR000) | 10.8 | 7.8 | 39.2% |
| Return on average assets | 5.5% | 6.0% | -44 bp |
| Return on average capital | 7.6% | 8.1% | -46 bp |
| Return on average invested capital | 7.4% | 7.9% | -43 bp |
| Total shareholders' equity / Total assets | 72.2% | 71.8% | -42 bp |
| EBIT / P&L interest expense | 80.4 | 73.3 | 9.8% |
| Net debt / EBITDA | 0.2 | 0.7 | -68.3% |
| Sales (in EURm) | 1-3 2023 | 1-3 2022 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 176.4 | 156.3 | 12.9% |
| Sales revenues of Podravka Group | 175.9 | 155.6 | 13.0% |
| Sales revenues of Food | 131.7 | 124.4 | 5.9% |
| Sales revenues of Pharma | 44.2 | 31.3 | 41.2% |
| Podravka Group's profitability (in EURm) | 1-3 2023 | 1-3 2022 | % change |
| Group's gross profit | 62.5 | 57.8 | 8.2% |
| Group's gross profit margin | 35.6% | 37.1% | -158 bp |
| Group's EBITDA | 27.3 | 22.6 | 20.7% |
| Group's EBITDA margin | 15.5% | 14.5% | +99 bp |
| Group's EBIT | 19.4 | 15.3 | 27.1% |
| Group's EBIT margin | 11.0% | 9.8% | +122 bp |
| Group's net profit after MI | 15.7 | 11.8 | 32.9% |
| Group's net profit margin after MI | 8.9% | 7.6% | +133 bp |
| Podravka Group's balance sheet (in EURm) | 31.3.2023 | 31.12.2022 | % change |
| Total assets | 765.2 | 736.2 | 3.9% |
| Shareholders' equity | 533.7 | 519.2 | 2.8% |
| Minority interests | 9.8 | 9.4 | 3.6% |
| Cash and cash equivalents | 41.4 | 21.9 | 88.9% |
| Financial debt | 87.1 | 84.0 | 3.6% |
| Net debt | 45.7 | 62.1 | -26.5% |
| Podravka Group's cash flow (in EURm) | 1-3 2023 | 1-3 2022 | % change |
| Net cash flow from operating activities | 30.9 | 42.2 | -26.6% |
| Capital expenditures | (11.8) | (8.4) | 39.9% |
| Depreciation and amortization | 7.9 | 7.3 | 7.4% |
| Free cash flow | 19.2 | 33.7 | -43.2% |
| Podravka Group's ratios and indicators | 31.3.2023 | 31.12.2022 | % change |
| Employee number at the end of period (in units) | 6,272 | 6,299 | -0.4% |
| P&L interest expense (in EURm) | 0.7 | 0.7 | -2.1% |
| Sales revenues / Number of employees (in EUR000) | 109.6 | 105.9 | 3.5% |
| Net profit after MI / Sales revenues (in EUR000) | 8.4 | 7.8 | 8.4% |
| Return on average assets | 6.0% | 6.0% | +9 bp |
| Return on average capital | 8.5% | 8.1% | +35 bp |
| Return on average invested capital | 8.0% | 7.8% | +15 bp |
| Total shareholders' equity / Total assets | 71.0% | 71.8% | -77 bp |
| EBIT / P&L interest expense | 81.0 | 73.3 | 10.5% |
| Net debt / EBITDA | 0.5 | 0.7 | -30.6% |
| Sales (in HRKm) | 2022 | 2021 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 5,154.9 | 4,666.5 | 10.5% |
| Sales revenues of Podravka Group | 5,026.8 | 4,631.5 | 8.5% |
| Sales revenues of Food | 3,934.2 | 3,601.3 | 9.2% |
| Sales revenues of Pharma | 1,092.6 | 1,030.3 | 6.0% |
| Podravka Group's profitability (in HRKm) | 2022 | 2021 | % change |
| Group's gross profit | 1,783.6 | 1,678.1 | 6.3% |
| Group's gross profit margin | 35.5% | 36.2% | -75 bp |
| Group's EBITDA | 707.2 | 592.0 | 19.5% |
| Group's EBITDA margin | 14.1% | 12.8% | +129 bp |
| Group's EBIT | 471.1 | 365.3 | 29.0% |
| Group's EBIT margin | 9.4% | 7.9% | +148 bp |
| Group's net profit after MI | 369.6 | 309.2 | 19.5% |
| Group's net profit margin after MI | 7.4% | 6.7% | +68 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2022 | 31.12.2021 | % change |
| Total assets | 5,547.1 | 4,909.0 | 13.0% |
| Shareholders' equity | 3,911.8 | 3,631.0 | 7.7% |
| Minority interests | 71.0 | 63.3 | 12.2% |
| Cash and cash equivalents | 165.1 | 33.3 | 395.7% |
| Financial debt | 633.2 | 493.8 | 28.2% |
| Net debt | 468.1 | 460.5 | 1.6% |
| Podravka Group's cash flow (in HRKm) | 2022 | 2021 | % change |
| Net cash flow from operating activities | 565.4 | 517.1 | 9.4% |
| Capital expenditures | (396.8) | (170.3) | 133.0% |
| Depreciation and amortization | 228.7 | 218.2 | 4.8% |
| Free cash flow | 168.6 | 346.8 | -51.4% |
| Podravka Group's ratios and indicators | 12/31/2022 | 12/31/2021 | % change |
| Employee number at the end of period (in units) | 6,299 | 6,557 | -3.9% |
| P&L interest expense (in HRKm) | 5.4 | 6.8 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 798.0 | 706.3 | 13.0% |
| Net profit after MI / Sales revenues (in HRK000) | 58.7 | 47.2 | 24.4% |
| Return on average assets | 6.1% | 6.3% | -25 bp |
| Return on average capital | 8.3% | 8.8% | -48 bp |
| Return on average invested capital | 7.6% | 7.7% | -8 bp |
| Total shareholders' equity / Total assets | 71.8% | 75.3% | -346 bp |
| EBIT / P&L interest expense | 73.3 | 56.9 | 28.8% |
| Net debt / EBITDA | 0.7 | 0.8 | -1.6% |
| Sales (in HRKm) | 1-9 2022 | 1-9 2021 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,741.4 | 3,410.4 | 9.7% |
| Sales revenues of Podravka Group | 3,712.6 | 3,383.5 | 9.7% |
| Sales revenues of Food | 2,926.0 | 2,634.0 | 11.1% |
| Sales revenues of Pharma | 786.6 | 749.5 | 5.0% |
| Podravka Group's profitability (in HRKm) | 1-9 2022 | 1-9 2021 | % change |
| Group's gross profit | 1,321.7 | 1,248.9 | 5.8% |
| Group's gross profit margin | 35.6% | 36.9% | -131 bp |
| Group's EBITDA | 519.9 | 491.7 | 5.7% |
| Group's EBITDA margin | 14.0% | 14.5% | -53 bp |
| Group's EBIT | 344.8 | 328.4 | 5.0% |
| Group's EBIT margin | 9.3% | 9.7% | -42 bp |
| Group's net profit after MI | 269.1 | 259.3 | 3.8% |
| Group's net profit margin after MI | 7.2% | 7.7% | -41 bp |
| Podravka Group's balance sheet (in HRKm) | 30.9.2022 | 31.12.2021 | % change |
| Total assets | 5,411.8 | 4,909.0 | 10.2% |
| Shareholders' equity | 3,798.7 | 3,631.0 | 4.6% |
| Minority interests | 69.2 | 63.3 | 9.4% |
| Cash and cash equivalents | 209.5 | 33.3 | 528.9% |
| Financial debt | 536.3 | 493.8 | 8.6% |
| Net debt | 326.9 | 460.5 | -29.0% |
| Podravka Group's cash flow (in HRKm) | 1-9 2022 | 1-9 2021 | % change |
| Net cash flow from operating activities | 519.5 | 453.4 | 14.6% |
| Capital expenditures | (292.8) | (100.3) | 191.9% |
| Depreciation and amortization | 170.9 | 163.3 | 4.7% |
| Free cash flow | 226.7 | 353.1 | -35.8% |
| Podravka Group's ratios and indicators | 30.9.2022 | 31.12.2021 | % change |
| Employee number at the end of period (in units) | 6,406 | 6,557 | -2.3% |
| P&L interest expense (in HRKm) | 5.6 | 6.8 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 774.4 | 706.3 | 9.6% |
| Net profit after MI / Sales revenues (in HRK000) | 49.8 | 47.2 | 5.6% |
| Return on average assets | 6.2% | 6.3% | -13 bp |
| Return on average capital | 8.5% | 8.8% | -29 bp |
| Return on average invested capital | 8.0% | 7.7% | +29 bp |
| Total shareholders' equity / Total assets | 71.5% | 75.3% | -378 bp |
| EBIT / P&L interest expense | 72.5 | 56.9 | 27.5% |
| Net debt / EBITDA | 0.5 | 0.8 | -31.7% |
| Sales (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,443.8 | 2,238.2 | 9.2% |
| Sales revenues of Podravka Group | 2,416.2 | 2,220.5 | 8.8% |
| Sales revenues of Food | 1,913.8 | 1,716.6 | 11.5% |
| Sales revenues of Pharma | 502.4 | 503.9 | -0.3% |
| Podravka Group's profitability (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
| Group's gross profit | 881.1 | 843.2 | 4.5% |
| Group's gross profit margin | 36.5% | 38.0% | -151 bp |
| Group's EBITDA | 365.2 | 356.6 | 2.4% |
| Group's EBITDA margin | 15.1% | 16.1% | -94 bp |
| Group's EBIT | 252.5 | 248.7 | 1.5% |
| Group's EBIT margin | 10.5% | 11.2% | -75 bp |
| Group's net profit after MI | 198.2 | 197.6 | 0.3% |
| Group's net profit margin after MI | 8.2% | 8.9% | -69 bp |
| Podravka Group's balance sheet (in HRKm) | 30.6.2022 | 31.12.2021 | % change |
| Total assets | 5,285.3 | 4,909.0 | 7.7% |
| Shareholders' equity | 3,732.8 | 3,631.0 | 2.8% |
| Minority interests | 68.1 | 63.3 | 7.6% |
| Cash and cash equivalents | 219.5 | 33.3 | 559.1% |
| Financial debt | 388.1 | 493.8 | -21.4% |
| Net debt | 168.6 | 460.5 | -63.4% |
| Podravka Group's cash flow (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
| Net cash flow from operating activities | 503.0 | 359.7 | 39.8% |
| Capital expenditures | (203.8) | (56.5) | 260.3% |
| Depreciation and amortization | 107.8 | 112.7 | -4.3% |
| Free cash flow | 299.3 | 303.2 | -1.3% |
| Podravka Group's ratios and indicators | 30.6.2022 | 31.12.2021 | % change |
| Employee number at the end of period (in units) | 6,545 | 6,557 | -0.2% |
| P&L interest expense (in HRKm) | 5.8 | 6.8 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 736.9 | 706.3 | 4.3% |
| Net profit after MI / Sales revenues (in HRK000) | 47.3 | 47.2 | 0.3% |
| Return on average assets | 6.1% | 6.3% | -26 bp |
| Return on average capital | 8.3% | 8.8% | -50 bp |
| Return on average invested capital | 7.9% | 7.7% | +20 bp |
| Total shareholders' equity / Total assets | 71.9% | 75.3% | -334 bp |
| EBIT / P&L interest expense | 66.9 | 56.9 | 17.6% |
| Net debt / EBITDA | 0.3 | 0.8 | -63.7% |
| Sales (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,177.3 | 1,089.8 | 8.0% |
| Sales revenues of Podravka Group | 1,172.6 | 1,079.7 | 8.6% |
| Sales revenues of Food | 936.9 | 845.3 | 10.8% |
| Sales revenues of Pharma | 235.7 | 234.3 | 0.6% |
| Podravka Group's profitability (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
| Group's gross profit | 435.6 | 411.8 | 5.8% |
| Group's gross profit margin | 37.1% | 38.1% | -100 bp |
| Group's EBITDA | 170.3 | 184.5 | -7.7% |
| Group's EBITDA margin | 14.5% | 17.1% | -257 bp |
| Group's EBIT | 115.2 | 131.1 | -12.2% |
| Group's EBIT margin | 9.8% | 12.1% | -232 bp |
| Group's net profit after MI | 88.8 | 105.2 | -15.6% |
| Group's net profit margin after MI | 7.6% | 9.7% | -217 bp |
| Podravka Group's balance sheet (in HRKm) | 31.3.2022 | 31.12.2021 | % change |
| Total assets | 5,215.0 | 4,909.0 | 6.2% |
| Shareholders' equity | 3,730.0 | 3,631.0 | 2.7% |
| Minority interests | 66.5 | 63.3 | 5.1% |
| Cash and cash equivalents | 214.8 | 33.3 | 545.0% |
| Financial debt | 435.8 | 493.8 | -11.8% |
| Net debt | 221.0 | 460.5 | -52.0% |
| Podravka Group's cash flow (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
| Net cash flow from operating activities | 317.6 | 190.6 | 66.6% |
| Capital expenditures | (63.4) | (18.8) | 237.8% |
| Depreciation and amortization | 55.2 | 53.4 | 3.3% |
| Free cash flow | 254.2 | 171.9 | 47.9% |
| Podravka Group's ratios and indicators | 31.3.2022 | 31.12.2021 | % change |
| Employee number at the end of period (in units) | 6,551 | 6,557 | -0.1% |
| P&L interest expense (in HRKm) | 6.3 | 6.8 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 721.2 | 706.3 | 2.1% |
| Net profit after MI / Sales revenues (in HRK000) | 44.7 | 47.2 | -5.2% |
| Return on average assets | 5.9% | 6.3% | -49 bp |
| Return on average capital | 7.9% | 8.8% | -86 bp |
| Return on average invested capital | 7.5% | 7.7% | -18 bp |
| Total shareholders' equity / Total assets | 72.8% | 75.3% | -246 bp |
| EBIT / P&L interest expense | 58.9 | 56.9 | 3.5% |
| Net debt / EBITDA | 0.4 | 0.8 | -50.9% |
| Sales (in HRKm) | 2021. | 2020. | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,666.5 | 4,526.5 | 3.1% |
| Sales revenues of Podravka Group | 4,631.5 | 4,503.2 | 2.8% |
| Sales revenues of Food | 3,601.3 | 3,527.0 | 2.1% |
| Sales revenues of Pharma | 1,030.3 | 976.2 | 5.5% |
| Podravka Group's profitability (in HRKm) | 2021. | 2020. | % change |
| Group's gross profit | 1,678.1 | 1,659.4 | 1.1% |
| Group's gross profit margin | 36.2% | 36.8% | -62 bp |
| Group's EBITDA | 592.0 | 546.7 | 8.3% |
| Group's EBITDA margin | 12.8% | 12.1% | +64 bp |
| Group's EBIT | 365.3 | 332.3 | 9.9% |
| Group's EBIT margin | 7.9% | 7.4% | +51 bp |
| Group's net profit after MI | 309.2 | 248.9 | 24.2% |
| Group's net profit margin after MI | 6.7% | 5.5% | +115 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2021. | 31.12.2021. | % change |
| Total assets | 4,909.0 | 4,940.6 | -0.6% |
| Shareholders' equity | 1,090.3 | 951.2 | 14.6% |
| Minority interests | 822.2 | 714.8 | 15.0% |
| Cash and cash equivalents | 33.3 | 51.9 | -35.8% |
| Financial debt | 493.8 | 785.2 | -37.1% |
| Net debt | 460.5 | 733.3 | -37.2% |
| Podravka Group's cash flow (in HRKm) | 2021. | 2020. | % change |
| Net cash flow from operating activities | 517.1 | 384.5 | 34.5% |
| Capital expenditures | (170.3) | (192.4) | -11.5% |
| Depreciation and amortization | 218.2 | 218.2 | -0.0% |
| Free cash flow | 346.8 | 192.0 | 80.6% |
| Podravka Group's ratios and indicators | 31.12.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,557 | 6,650 | -1.4% |
| P&L interest expense (in HRKm) | 6.8 | 11.5 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 706.3 | 677.2 | 4.3% |
| Net profit after MI / Sales revenues (in HRK000) | 47.2 | 37.4 | 26.0% |
| Return on average assets | 6.3% | 5.1% | +123 bp |
| Return on average capital | 8.8% | 7.6% | +121 bp |
| Return on average invested capital | 7.2% | 6.6% | +56 bp |
| Total shareholders' equity / Total assets | 75.3% | 69.4% | +589 bp |
| EBIT / P&L interest expense | 56.9 | 28.3 | 101.1% |
| Net debt / EBITDA | 0.8 | 1.4 | -43.9% |
| Sales (in HRKm) | 1-9 2021 | 1-9 2020 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,410.4 | 3,339.5 | 2.1% |
| Sales revenues of Podravka Group | 3,383.5 | 3,328.6 | 1.6% |
| Sales revenues of Food | 2,634.0 | 2,619.7 | 0.5% |
| Sales revenues of Pharma | 749.5 | 708.9 | 5.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2021 | 1-9 2020 | % change |
| Group's gross profit | 1,248.9 | 1,232.5 | 1.3% |
| Group's gross profit margin | 36.9% | 37.0% | -12 bp |
| Group's EBITDA | 491.7 | 435.5 | 12.9% |
| Group's EBITDA margin | 14.5% | 13.1% | +145 bp |
| Group's EBIT | 328.4 | 272.7 | 20.4% |
| Group's EBIT margin | 9.7% | 8.2% | +151 bp |
| Group's net profit after MI | 259.3 | 210.1 | 23.4% |
| Group's net profit margin after MI | 7.7% | 6.3% | +135 bp |
| Podravka Group's balance sheet (in HRKm) | 30.9.2021 | 31.12.2020 | % change |
| Total assets | 5,113.7 | 4,940.6 | 3.5% |
| Shareholders' equity | 3,577.3 | 3,372.1 | 6.1% |
| Minority interests | 61.1 | 54.9 | 11.3% |
| Cash and cash equivalents | 163.5 | 51.9 | 215.3% |
| Financial debt | 613.5 | 785.2 | -21.9% |
| Net debt | 450.0 | 733.3 | -38.6% |
| Podravka Group's cash flow (in HRKm) | 1-9 2021 | 1-9 2020 | % change |
| Net cash flow from operating activities | 453.4 | 290.5 | 56.1% |
| Capital expenditures | (100.3) | (139.8) | -28.2% |
| Depreciation and amortization | 163.3 | 162.8 | 0.3% |
| Free cash flow | 353.1 | 150.7 | 134.3% |
| Podravka Group's ratios and indicators | 30.9.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,746 | 6,650 | 1.4% |
| P&L interest expense (in HRKm) | 7.9 | 11.5 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 675.7 | 677.2 | -0.2% |
| Net profit after MI / Sales revenues (in HRK000) | 44.2 | 37.4 | 18.0% |
| Return on average assets | 6.0% | 5.1% | +89 bp |
| Return on average capital | 8.6% | 7.6% | +99 bp |
| Return on average invested capital | 7.7% | 6.6% | +107 bp |
| Total shareholders' equity / Total assets | 71.2% | 69.4% | +179 bp |
| EBIT / P&L interest expense | 48.2 | 28.3 | 70.5% |
| Net debt / EBITDA | 0.7 | 1.4 | -44.5% |
| Sales (in HRKm) | 1-6 2021 | 1-6 2020 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,238.2 | 2,252.3 | -0.6% |
| Sales revenues of Podravka Group | 2,220.5 | 2,245.3 | -1.1% |
| Sales revenues of Food | 1,716.6 | 1,755.0 | -2.2% |
| Sales revenues of Pharma | 503.9 | 490.3 | 2.8% |
| Podravka Group's profitability (in HRKm) | 1-6 2021 | 1-6 2020 | % change |
| Group's gross profit | 843.2 | 835.9 | 0.9% |
| Group's gross profit margin | 38.0% | 37.2% | +75 bp |
| Group's EBITDA | 356.6 | 320.1 | 11.4% |
| Group's EBITDA margin | 16.1% | 14.3% | +180 bp |
| Group's EBIT | 248.7 | 211.7 | 17.5% |
| Group's EBIT margin | 11.2% | 9.4% | +177 bp |
| Group's net profit after MI | 197.6 | 161.6 | 22.3% |
| Group's net profit margin after MI | 8.9% | 7.2% | +170 bp |
| Podravka Group's balance sheet (in HRKm) | 30.6.2021 | 31.12.2020 | % change |
| Total assets | 5,105.7 | 4,940.6 | 3.3% |
| Shareholders' equity | 3,513.0 | 3,372.1 | 4.2% |
| Minority interests | 59.0 | 54.9 | 7.4% |
| Cash and cash equivalents | 220.2 | 51.9 | 324.6% |
| Financial debt | 646.5 | 785.2 | -17.7% |
| Net debt | 426.3 | 733.3 | -41.9% |
| Podravka Group's cash flow (in HRKm) | 1-6 2021 | 1-6 2020 | % change |
| Net cash flow from operating activities | 359.7 | 280.0 | 28.5% |
| Capital expenditures | (56.5) | (91.3) | -38.1% |
| Depreciation and amortization | 107.8 | 108.4 | -0.5% |
| Free cash flow | 303.2 | 188.7 | 60.7% |
| Podravka Group's ratios and indicators | 30.6.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,737 | 6,650 | 1.3% |
| P&L interest expense (in HRKm) | 9.2 | 11.5 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 664.7 | 677.2 | -1.8% |
| Net profit after MI / Sales revenues (in HRK000) | 42.3 | 37.4 | 13.0% |
| Return on average assets | 5.8% | 5.1% | +65 bp |
| Return on average capital | 8.3% | 7.6% | +72 bp |
| Return on average invested capital | 7.4% | 6.6% | +78 bp |
| Total shareholders' equity / Total assets | 70.0% | 69.4% | +60 bp |
| EBIT / P&L interest expense | 39.5 | 28.3 | 39.8% |
| Net debt / EBITDA | 0.7 | 1.4 | -45.8% |
| Sales (in HRKm) | 1-3 2021 | 1-3 2020 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,089.8 | 1,231.9 | -11.5% |
| Sales revenues of Podravka Group | 1,079.7 | 1,228.7 | -12.1% |
| Sales revenues of Food | 845.3 | 970.9 | -12.9% |
| Sales revenues of Pharma | 234.3 | 257.9 | -9.1% |
| Podravka Group's profitability (in HRKm) | 1-3 2021 | 1-3 2020 | % change |
| Group's gross profit | 411.8 | 457.2 | -9.9% |
| Group's gross profit margin | 38.1% | 37.2% | +94 bp |
| Group's EBITDA | 184.5 | 177.2 | 4.2% |
| Group's EBITDA margin | 17.1% | 14.4% | +267 bp |
| Group's EBIT | 131.1 | 123.0 | 6.6% |
| Group's EBIT margin | 12.1% | 10.0% | +214 bp |
| Group's net profit after MI | 105.2 | 91.0 | 15.6% |
| Group's net profit margin after MI | 9.7% | 7.4% | +234 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2021 | 31.12.2020 | % change |
| Total assets | 5,126.9 | 4,940.6 | 3.8% |
| Shareholders' equity | 3,486.3 | 3,372.1 | 3.4% |
| Minority interests | 57.4 | 54.9 | 4.6% |
| Cash and cash equivalents | 178.1 | 51.9 | 243.4% |
| Financial debt | 785.2 | 744.7 | -5.2% |
| Net debt | 733.3 | 566.6 | -22.7% |
| Podravka Group's cash flow (in HRKm) | 1-3 2021 | 1-3 2020 | % change |
| Net cash flow from operating activities | 190.6 | 134.5 | 41.7% |
| Capital expenditures | 18.8 | 47.2 | -60.2% |
| Depreciation and amortization | 53.4 | 54.2 | -1.4% |
| Free cash flow | 171.8 | 87.3 | 96.8% |
| Podravka Group's ratios and indicators | 31.03.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,668 | 6,650 | 0.3% |
| P&L interest expense (in HRKm) | 10.4 | 11.5 | -9.7% |
| Sales revenues / Number of employees (in HRK000) | 653.0 | 677.2 | -3.6% |
| Net profit after MI / Sales revenues (in HRK000) | 39.5 | 37.4 | 5.4% |
| Return on average assets | 5.3% | 5.1% | +18 bp |
| Return on average capital | 7.7% | 7.6% | +9 bp |
| Return on average invested capital | 6.7% | 6.5% | +17 bp |
| Total shareholders' equity / Total assets | 69.1% | 69.4% | -24 bp |
| EBIT / P&L interest expense | 32.4 | 28.3 | 14.5% |
| Net debt / EBITDA | 1.0 | 1.4 | -24.2% |
| Sales (in HRKm) | 2020 | 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,526.5 | 4,460.2 | 1.5% |
| Sales revenues of Podravka Group | 4,503.2 | 4,409.4 | 2.1% |
| Sales revenues of Food | 3,527.0 | 3,454.0 | 2.1% |
| Sales revenues of Pharma | 976.2 | 955.4 | 2.2% |
| Podravka Group's profitability (in HRKm) | 2020 | 2019 | % change |
| Group's gross profit | 1,659.4 | 1,631.5 | 1.7% |
| Group's gross profit margin | 36.8% | 37.0% | -15 bp |
| Group's EBITDA | 546.7 | 509.0 | 7.4% |
| Group's EBITDA margin | 12.1% | 11.5% | +60 bp |
| Group's EBIT | 332.3 | 283.5 | 17.2% |
| Group's EBIT margin | 7.4% | 6.4% | + 95 bp |
| Group's net profit after MI | 248.9 | 221.6 | 12.3% |
| Group's net profit margin after MI | 5.5% | 5.0% | +50 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2020 | 31.12.2019 | % change |
| Total assets | 4,940.6 | 4,883.8 | 1.2% |
| Shareholders' equity | 3,372.1 | 3,173.1 | 6.3% |
| Minority interests | 54.9 | 46.3 | 18.5% |
| Cash and cash equivalents | 51.9 | 55.6 | -6.6% |
| Financial debt | 785.2 | 878.0 | -10.6% |
| Net debt | 733.3 | 822.4 | -10.8% |
| Podravka Group's cash flow (in HRKm) | 2020 | 2019 | % change |
| Net cash flow from operating activities | 384.5 | 272.9 | 40.9% |
| Capital expenditures | 192.4 | 153.9 | 25.0% |
| Depreciation and amortization | 218.2 | 216.0 | 1.0% |
| Free cash flow | 192.1 | 119.0 | 61.4% |
| Podravka Group's ratios and indicators | 31.12.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,650 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 11.5 | 14.9 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 677.2 | 662.9 | 2.2% |
| Net profit after MI / Sales revenues (in HRK000) | 37.4 | 33.3 | 12.4% |
| Return on average assets | 5.1% | 4.7% | +41 bp |
| Return on average capital | 7.6% | 7.3% | +26 bp |
| Return on average invested capital | 6.5% | 6.3% | +23 bp |
| Total shareholders' equity / Total assets | 69.4% | 65.9% | +344 bp |
| EBIT / P&L interest expense | 28.3 | 20.1 | 40.5% |
| Net debt / EBITDA | 1.4 | 1.6 | -15.3% |
| Sales (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,339.5 | 3,261.3 | 2.4% |
| Sales revenues of Podravka Group | 3,328.6 | 3,238.5 | 2.8% |
| Sales revenues of Food | 2,619.7 | 2,550.3 | 2.7% |
| Sales revenues of Pharma | 708.9 | 688.2 | 3.0% |
| Podravka Group's profitability (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
| Group's gross profit | 1,232.5 | 1,206.1 | 2.2% |
| Group's gross profit margin | 37.0% | 37.2% | -21 bp |
| Group's EBITDA | 435.5 | 413.2 | 5.4% |
| Group's EBITDA margin | 13.1% | 12.8% | +33 bp |
| Group's EBIT | 272.7 | 252.2 | 8.1% |
| Group's EBIT margin | 8.2% | 7.8% | +41 bp |
| Group's net profit after MI | 210.1 | 194.3 | 8.1% |
| Group's net profit margin after MI | 6.3% | 6.0% | +31 bp |
| Podravka Group's balance sheet (in HRKm) | 30.9.2020 | 31.12.2019 | % change |
| Total assets | 5,102.8 | 4,883.8 | 4.5% |
| Shareholders' equity | 3,329.6 | 3,173.1 | 4.9% |
| Minority interests | 50.7 | 46.3 | 9.4% |
| Cash and cash equivalents | 131.2 | 55.6 | 136.0% |
| Financial debt | 888.7 | 878.0 | 1.2% |
| Net debt | 757.5 | 822.4 | -7.9% |
| Podravka Group's cash flow (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
| Net cash flow from operating activities | 290.5 | 175.7 | 65.3% |
| Capital expenditures | 139.8 | 101.4 | -37.8% |
| Depreciation and amortization | 162.8 | 161.1 | 1.1% |
| Free cash flow | 150.7 | 74.3 | 102.9% |
| Podravka Group's ratios and indicators | 30.9.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,807 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 11.8 | 14.9 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 661.0 | 662.9 | -0.3% |
| Net profit after MI / Sales revenues (in HRK000) | 34.9 | 33.3 | 4.7% |
| Return on average assets | 4.9% | 4.7% | +20 bp |
| Return on average capital | 7.4% | 7.3% | +11 bp |
| Return on average invested capital | 6.5% | 6.3% | +29 bp |
| Total shareholders' equity / Total assets | 66.2% | 65.9% | +32 bp |
| EBIT / P&L interest expense | 27.0 | 20.1 | 33.9% |
| Net debt / EBITDA | 1.4 | 1.6 | -11.2% |
| Sales (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,235.3 | 2,156.2 | 3.7% |
| Sales revenues of Podravka Group | 2,245.3 | 2,139.5 | 4.9% |
| Sales revenues of Food | 1,755.0 | 1,684.3 | 4.2% |
| Sales revenues of Pharma | 490.3 | 455.2 | 7.7% |
| Podravka Group's profitability (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
| Group's gross profit | 835.9 | 803.8 | 4.0% |
| Group's gross profit margin | 37.2% | 37.6% | -34 bp |
| Group's EBITDA | 320.1 | 288.6 | 10.9% |
| Group's EBITDA margin | 14.3% | 13.5% | +77 bp |
| Group's EBIT | 211.7 | 182.9 | 15.8% |
| Group's EBIT margin | 9.4% | 8.5% | +88 bp |
| Group's net profit after MI | 161.6 | 140.0 | 15.4% |
| Group's net profit margin after MI | 7.2% | 6.5% | +65 bp |
| Podravka Group's balance sheet (in HRKm) | 30.6.2020 | 31.12.2019 | % change |
| Total assets | 5,100.9 | 4,883.8 | 4.4% |
| Shareholders' equity | 3,279.2 | 3,173.1 | 3.3% |
| Minority interests | 49.3 | 46.3 | 6.4% |
| Cash and cash equivalents | 249.2 | 55.6 | 348.3% |
| Financial debt | 966.0 | 878.0 | 10.0% |
| Net debt | 716.8 | 822.4 | -12.8% |
| Podravka Group's cash flow (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
| Net cash flow from operating activities | 280.0 | 152.8 | 83.3% |
| Capital expenditures | 91.3 | 65.6 | 39.3% |
| Depreciation and amortization | 108.4 | 105.8 | 2.5% |
| Free cash flow | 188.7 | 87.2 | 116.4% |
| Podravka Group's ratios and indicators | 30.6.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,785 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 12.5 | 14.9 | -15.8% |
| Sales revenues / Number of employees (in HRK000) | 665.5 | 662.9 | 0.4% |
| Net profit after MI / Sales revenues (in HRK000) | 35.8 | 33.3 | 7.6% |
| Return on average assets | 5.0% | 4.7% | +26 bp |
| Return on average capital | 7.6% | 7.3% | +27 bp |
| Return on average invested capital | 6.5% | 6.3% | +29 bp |
| Total shareholders' equity / Total assets | 65.3% | 65.9% | -67 bp |
| EBIT / P&L interest expense | 25.8 | 20.1 | 28.1% |
| Net debt / EBITDA | 1.3 | 1.6 | -17.0% |
| Sales (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,198.0 | 1,030.6 | 16.2% |
| Sales revenues of Podravka Group | 1,228.7 | 1,017.4 | 20.8% |
| Sales revenues of Food | 970.9 | 815.5 | 19.1% |
| Sales revenues of Pharma | 257.9 | 201.9 | 27.7% |
| Podravka Group's profitability (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
| Group's gross profit | 457.2 | 384.0 | 19.1% |
| Group's gross profit margin | 37.2% | 37.7% | -54 bp |
| Group's EBITDA | 177.2 | 156.5 | 13.2% |
| Group's EBITDA margin | 14.4% | 15.4% | -96 bp |
| Group's EBIT | 123.0 | 104.4 | 17.8% |
| Group's EBIT margin | 10.0% | 10.3% | -25 bp |
| Group's net profit after MI | 91.0 | 80.1 | 13.5% |
| Group's net profit margin after MI | 7.4% | 7.9% | -47 bp |
| Podravka Group's balance sheet (in HRKm) | 31.3.2020 | 31.12.2019 | % change |
| Total assets | 5,264.0 | 4,883.8 | 7.8% |
| Shareholders' equity | 3,275.7 | 3,173.1 | 3.2% |
| Minority interests | 47.6 | 46.3 | 2.8% |
| Cash and cash equivalents | 264.9 | 55.6 | 376.5% |
| Financial debt | 1,021.1 | 878.0 | 16.3% |
| Net debt | 756.2 | 822.4 | -8.0% |
| Podravka Group's cash flow (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
| Net cash flow from operating activities | 134.5 | 50.3 | 167.6% |
| Capital expenditures | 47.2 | 24.1 | 95.7% |
| Depreciation and amortization | 54.2 | 52.1 | 4.1% |
| Free cash flow | 87.4 | 26.2 | 234.0% |
| Podravka Group's ratios and indicators | 31.3.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,756 | 6,652 | 1.6% |
| P&L interest expense (in HRKm) | 13.7 | 14.9 | -8.0% |
| Sales revenues / Number of employees (in HRK000) | 683.9 | 662.9 | 3.2% |
| Net profit after MI / Sales revenues (in HRK000) | 34.4 | 33.3 | 3.3% |
| Return on average assets | 4.7% | 4.7% | +1 bp |
| Return on average capital | 7.3% | 7.3% | +1 bp |
| Return on average invested capital | 5.6% | 5.9% | -33 bp |
| Total shareholders' equity / Total assets | 63.1% | 65.9% | -279 bp |
| EBIT / P&L interest expense | 23.1 | 20.1 | 14.6% |
| Net debt / EBITDA | 1.4 | 1.6 | -11.2% |
| Sales (in HRKm) | 2019 | 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,460.2 | 4,240.5 | 5.2% |
| Sales revenues of Podravka Group | 4,409.4 | 4,232.1 | 4.2% |
| Sales revenues of Food | 3,454.0 | 3,335.3 | 3.6% |
| Sales revenues of Pharma | 955.4 | 896.9 | 6.5% |
| Podravka Group's profitability (in HRKm) | 2019 | 2018 | % change |
| Group's gross profit | 1,631.5 | 1,558.4 | 4.7% |
| Group's gross profit margin | 37.0% | 36.8% | +18 bp |
| Group's EBITDA | 509.0 | 463.7 | 9.8% |
| Group's EBITDA margin | 11.5% | 11.0% | +59 bp |
| Group's EBIT | 283.5 | 258.4 | 9.7% |
| Group's EBIT margin | 6.4% | 6.1% | +32 bp |
| Group's net profit after MI | 221.6 | 205.7 | 7.7% |
| Group's net profit margin after MI | 5.0% | 4.9% | +16 bp |
| Podravka Group's balance sheet (in HRKm) | 2019 | 2018 | % change |
| Total assets | 4,883.8 | 4,846.1 | 0.8% |
| Shareholders' equity | 3,173.1 | 3,005.3 | 5.6% |
| Minority interests | 46.3 | 42.4 | 9.4% |
| Cash and cash equivalents | 55.6 | 211.1 | -73.7% |
| Financial debt | 878.0 | 966.2 | -9.1% |
| Net debt | 822.4 | 755.1 | 8.9% |
| Podravka Group's cash flow (in HRKm) | 31.12.2019 | 31.12.2018 | % change |
| Net cash flow from operating activities | 272.9 | 316.9 | -13.9% |
| Capital expenditures | 153.9 | 166.1 | -7.4% |
| Depreciation and amortization | 216.0 | 192.7 | 12.1% |
| Free cash flow | 119.0 | 150.8 | -21.1% |
| Podravka Group's ratios and indicators | 31.12.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,652.0 | 6,516 | 2.1% |
| P&L interest expense (in HRKm) | 14.9 | 17.93 | -17.0% |
| Sales revenues / Number of employees (in HRK000) | 662.9 | 649.50 | 2.1% |
| Net profit after MI / Sales revenues (in HRK000) | 33.3 | 31.57 | 5.5% |
| Return on average assets | 0.0 | 4.49% | +22 bp |
| Return on average capital | 0.1 | 7.48% | -17 bp |
| Return on average invested capital | 0.1 | 6.30% | -37 bp |
| Total shareholders' equity / Total assets | 0.7 | 62.89% | +303 bp |
| EBIT / P&L interest expense | 20.1 | 15.2 | 32.7% |
| Net debt / EBITDA | 1.6 | 1.6 | -1.8% |
| Sales (in HRKm) | 1-9 2019 | 1-9 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,261.3 | 3,088.1 | 5.6% |
| Sales revenues of Podravka Group | 3,238.5 | 3,078.3 | 5.2% |
| Sales revenues of Food | 2,550.3 | 2,439.0 | 4.6% |
| Sales revenues of Pharma | 688.2 | 639.3 | 7.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2019 | 1-9 2018 | % change |
| Group's gross profit | 1,206.1 | 1,144.2 | 5.4% |
| Group's gross profit margin | 37.2% | 37.2% | +7 bp |
| Group's EBITDA | 413.2 | 379.4 | 8.9% |
| Group's EBITDA margin | 12.8% | 12.3% | +43 bp |
| Group's EBIT | 252.2 | 238.8 | 5.6% |
| Group's EBIT margin | 7.8% | 7.8% | +3 bp |
| Group's net profit after MI | 194.3 | 185.9 | 4.5% |
| Group's net profit margin after MI | 6.0% | 6.0% | -4 bp |
| Podravka Group's balance sheet (in HRKm) | 1-9 2019 | 1-9 2018 | % change |
| Total assets | 4,985.4 | 4,846.1 | 2.9% |
| Shareholders' equity | 3,137.2 | 3,005.3 | 4.4% |
| Minority interests | 45.6 | 42.4 | 7.6% |
| Cash and cash equivalents | 129.3 | 211.1 | -38.7% |
| Financial debt | 984.6 | 966.2 | 1.9% |
| Net debt | 855.2 | 755.1 | 13.3% |
| Podravka Group's cash flow (in HRKm) | 30.09.2019 | 31.12.2018 | % change |
| Net cash flow from operating activities | 219.4 | 146.6 | 49.7% |
| Capital expenditures | 101.4 | 108.5 | -6.5% |
| Depreciation and amortization | 161.1 | 140.6 | 14.5% |
| Free cash flow | 118.0 | 38.1 | 209.7% |
| Podravka Group's ratios and indicators | 30.09.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,872 | 6,517 | 5.4% |
| P&L interest expense (in HRKm) | 15.5 | 17.9 | -13.8% |
| Sales revenues / Number of employees (in HRK000) | 639.2 | 649.4 | -1.6% |
| Net profit after MI / Sales revenues (in HRK000) | 31.1 | 31.6 | -1.3% |
| Return on average assets | 4.5% | 4.3% | +19 bp |
| Return on average capital | 7.0% | 7.1% | -8 bp |
| Return on average invested capital | 5.7% | 5.4% | +25 bp |
| Total shareholders' equity / Total assets | 63.8% | 62.9% | +95 bp |
| EBIT / P&L interest expense | 17.6 | 14.4 | 22.0% |
| Net debt / EBITDA | 1.7 | 1.6 | 5.6% |
| Sales (in HRKm) | 1-6 2019 | 1-6 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,156.2 | 2,031.7 | 6.1% |
| Sales revenues of Podravka Group | 2,139.5 | 2,035.1 | 5.1% |
| Sales revenues of Food | 1,684.3 | 1,602.2 | 5.1% |
| Sales revenues of Pharma | 455.2 | 432.8 | 5.2% |
| Podravka Group's profitability (in HRKm) | 1-6 2019 | 1-6 2018 | % change |
| Group's gross profit | 803.8 | 760.6 | 5.7% |
| Group's gross profit margin | 37.6% | 37.4% | +19 bp |
| Group's EBITDA | 288.6 | 243.5 | 18.5% |
| Group's EBITDA margin | 13.5% | 12.0% | +152 bp |
| Group's EBIT | 182.9 | 149.2 | 22.6% |
| Group's EBIT margin | 8.5% | 7.3% | +122 bp |
| Group's net profit after MI | 140.0 | 120.7 | 16.1% |
| Group's net profit margin after MI | 6.5% | 5.9% | +62 bp |
| Podravka Group's balance sheet (in HRKm) | 1-6 2019 | 1-6 2018 | % change |
| Total assets | 4,939.8 | 4,846.1 | 1.9% |
| Shareholders' equity | 3,080.8 | 3,005.3 | 2.5% |
| Minority interests | 44.6 | 42.4 | 5.3% |
| Cash and cash equivalents | 146.9 | 211.1 | -30.4% |
| Financial debt | 922.8 | 966.2 | -4.5% |
| Net debt | 775.9 | 755.1 | 2.7% |
| Podravka Group's cash flow (in HRKm) | 30.06.2019 | 31.12.2018 | % change |
| Net cash flow from operating activities | 152.8 | 99.0 | 53.8% |
| Capital expenditures | 65.6 | 67.4 | -2.7% |
| Depreciation and amortization | 105.8 | 94.3 | 12.1% |
| Free cash flow | 87.2 | 31.6 | 175.8% |
| Podravka Group's ratios and indicators | 30.06.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,793 | 6,517 | 4.2% |
| P&L interest expense (in HRKm) | 16.5 | 17.9 | -8.2% |
| Sales revenues / Number of employees (in HRK000) | 638.4 | 649.4 | -1.7% |
| Net profit after MI / Sales revenues (in HRK000) | 33.1 | 31.6 | 4.9% |
| Return on average assets | 5.0% | 4.5% | +52 bp |
| Return on average capital | 7.9% | 7.5% | +46 bp |
| Return on average invested capital | 6.2% | 5.4% | +37 bp |
| Total shareholders' equity / Total assets | 63.3% | 62.9% | +38 bp |
| EBIT / P&L interest expense | 18.7 | 15.2 | 23.5% |
| Net debt / EBITDA | 1.5 | 1.6 | -6.8% |
| Sales (in HRKm) | 1-3 2019 | 1-3 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,030.6 | 987.1 | 4.4% |
| Sales revenues of Podravka Group | 1,017.4 | 988.9 | 2.9% |
| Sales revenues of Food | 815.5 | 789.8 | 3.3% |
| Sales revenues of Pharma | 201.9 | 199.0 | 1.4% |
| Podravka Group's profitability (in HRKm) | 1-3 2019 | 1-3 2018 | % change |
| Group's gross profit | 384.0 | 371.5 | 3.4% |
| Group's gross profit margin | 37.7% | 37.6% | +17 bp |
| Group's EBITDA | 156.5 | 135.6 | 15.4% |
| Group's EBITDA margin | 15.4% | 13.7% | +166 bp |
| Group's EBIT | 104.4 | 87.7 | 19.1% |
| Group's EBIT margin | 10.3% | 8.9% | +139 bp |
| Group's net profit after MI | 80.1 | 69.8 | 14.8% |
| Group's net profit margin after MI | 7.9% | 7.1% | +82 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2019 | 31.12.2018 | % change |
| Total assets | 4,904.6 | 4,846.1 | 1.2% |
| Shareholders' equity | 3,086.5 | 3,005.3 | 2.7% |
| Minority interests | 43.9 | 42.4 | 3.5% |
| Cash and cash equivalents | 145.1 | 211.1 | -31.3% |
| Financial debt | 984.2 | 966.2 | 1.9% |
| Net debt | 839.1 | 755.1 | 11.1% |
| Podravka Group's cash flow (in HRKm) | 1-3 2019 | 1-3 2018 | % change |
| Net cash flow from operating activities | 50.3 | -41.4 | -221.3% |
| Capital expenditures | 24.1 | 24.5 | -1.5% |
| Depreciation and amortization | 52.1 | 47.9 | 8.6% |
| Free cash flow | 26.2 | (65.9) | -139.7% |
| Podravka Group's ratios and indicators | 31.03.2019 | 31.12.2018 | % change |
| Employee number at the end of period (in units) | 6,657 | 6,517 | 2.1% |
| P&L interest expense (in HRKm) | 17.1 | 17.9 | -4.6% |
| Sales revenues / Number of employees (in HRK000) | 640.0 | 649.4 | -1.4% |
| Net profit after MI / Sales revenues (in HRK000) | 32.5 | 31.6 | 2.8% |
| Return on average assets | 4.6% | 4.3% | +29 bp |
| Return on average capital | 7.2% | 7.1% | +8 bp |
| Return on average invested capital | 5.8% | 5.4% | +37 bp |
| Total shareholders' equity / Total assets | 63.8% | 62.9% | +93 bp |
| EBIT / P&L interest expense | 16.1 | 14.4 | 11.6% |
| Net debt / EBITDA | 1.7 | 1.6 | 6.3% |
| Sales (in HRKm) | 1-12 2018 | 1-12 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,240.5 | 4,110.9 | 3.2% |
| Sales revenues of Podravka Group | 4,232.1 | 4,111.2 | 2.9% |
| Sales revenues of Food | 3,335.3 | 3,243.7 | 2.8% |
| Sales revenues of Pharma | 896.9 | 867.5 | 3.4% |
| Podravka Group's profitability (in HRKm) | 1-12 2018 | 1-12 2017 | % change |
| Group's gross profit | 1,558.4 | 1,484.1 | 5.0% |
| Group's gross profit margin | 36.8% | 36.1% | +72 bp |
| Group's EBITDA | 463.7 | 374.1 | 24.0% |
| Group's EBITDA margin | 11.0% | 9.1% | +186 bp |
| Group's EBIT | 258.4 | 91.1 | 183.8% |
| Group's EBIT margin | 6.1% | 2.2% | +389 bp |
| Group's net profit after MI | 205.7 | 18.2 | 1027.2% |
| Group's net profit margin after MI | 4.9% | 0.4% | +442 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2018 | 31.12.2017 | % change |
| Total assets | 4,846.1 | 5,061.4 | -4.3% |
| Shareholders' equity | 3,005.3 | 2,860.1 | 5.1% |
| Minority interests | 42.4 | 36.7 | 15.5% |
| Cash and cash equivalents | 211.1 | 362.1 | -41.7% |
| Financial debt | 966.2 | 1,271.1 | -24.0% |
| Net debt | 755.1 | 909.1 | -16.9% |
| Podravka Group's cash flow (in HRKm) | 1-12 2018 | 1-12 2017 | % change |
| Net cash flow from operating activities | 316.9 | 473.4 | -33.1% |
| Capital expenditures | 166.1 | 206.8 | -19.7% |
| Depreciation and amortization | 192.7 | 194.0 | -0.7% |
| Free cash flow | 150.8 | 266.6 | -43.4% |
| Podravka Group's ratios and indicators | 31.12.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,517 | 6,306 | 3.3% |
| P&L interest expense (in HRKm) | 17.9 | 26.9 | -33.3% |
| Sales revenues / Number of employees (in HRK000) | 649.4 | 651.9 | -0.4% |
| Net profit after MI / Sales revenues (in HRK000) | 31.6 | 2.9 | 990.7% |
| Return on average assets | 4.3% | 0.5% | +381 bp |
| Return on average capital | 7.1% | 0.8% | +630 bp |
| Return on average invested capital | 5.4% | 1.9% | +351 bp |
| Total shareholders' equity / Total assets | 62.9% | 57.2% | +566 bp |
| EBIT / P&L interest expense | 14.4 | 3.4 | 325.3% |
| Net debt / EBITDA | 1.6 | 2.4 | -33.0% |
| Sales (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,088.1 | 2,979.5 | 3.6% |
| Sales revenues of Podravka Group | 3,078.3 | 2,983.1 | 3.2% |
| Sales revenues of Food | 2,439.0 | 2,372.3 | 2.8% |
| Sales revenues of Pharma | 639.3 | 610.8 | 4.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
| Group's gross profit | 1,144.2 | 1,061.7 | 7.8% |
| Group's gross profit margin | 37.2% | 35.6% | +158 bp |
| Group's EBITDA | 379.4 | 254.4 | 49.1% |
| Group's EBITDA margin | 12.3% | 8.5% | +380 bp |
| Group's EBIT | 238.8 | 110.5 | 116.0% |
| Group's EBIT margin | 7.8% | 3.7% | +405 bp |
| Group's net profit after MI | 185.9 | 54.1 | 243.8% |
| Group's net profit margin after MI | 6.0% | 1.8% | +423 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2018 | 31.12.2017 | % change |
| Total assets | 4,848.1 | 5,061.4 | -4.2% |
| Shareholders' equity | 2,987.1 | 2,860.1 | 4.4% |
| Minority interests | 40.5 | 36.7 | 10.5% |
| Cash and cash equivalents | 146.0 | 362.1 | -59.7% |
| Financial debt | 1,015.1 | 1,271.1 | -20.1% |
| Net debt | 869.1 | 909.1 | -4.4% |
| Podravka Group's cash flow (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
| Net cash flow from operating activities | 146.6 | 193.1 | -24.1% |
| Capital expenditures | 108.5 | 158.8 | -31.6% |
| Depreciation and amortization | 140.6 | 143.8 | -2.2% |
| Free cash flow | 38.1 | 34.3 | 11.0% |
| Podravka Group's ratios and indicators | 30.09.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,626 | 6,306 | 5.1% |
| P&L interest expense (in HRKm) | 20.5 | 26.9 | -23.8% |
| Sales revenues / Number of employees (in HRK000) | 634.8 | 651.9 | -2.6% |
| Net profit after MI / Sales revenues (in HRK000) | 22.7 | 2.9 | 682.8% |
| Return on average assets | 3.1% | 0.5% | +266 bp |
| Return on average capital | 5.2% | 0.8% | +439 bp |
| Return on average invested capital | 4.7% | 1.9% | +275 bp |
| Total shareholders' equity / Total assets | 62.5% | 57.2% | +522 bp |
| EBIT / P&L interest expense | 10.7 | 3.4 | 216.1% |
| Net debt / EBITDA | 1.7 | 2.4 | -28.3% |
| Sales (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,031.7 | 1,944.0 | 4.5% |
| Sales revenues of Podravka Group | 2,035.1 | 1,951.2 | 4.3% |
| Sales revenues of Food | 1,602.2 | 1,544.4 | 3.7% |
| Sales revenues of Pharma | 432.8 | 406.8 | 6.4% |
| Podravka Group's profitability (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
| Group's gross profit | 760.6 | 693.7 | 9.7% |
| Group's gross profit margin | 37.4% | 35.6% | +182 bp |
| Group's EBITDA | 243.5 | 140.0 | 74.0% |
| Group's EBITDA margin | 12.0% | 7.2% | +479 bp |
| Group's EBIT | 149.2 | 44.8 | 233.2% |
| Group's EBIT margin | 7.3% | 2.3% | +504 bp |
| Group's net profit after MI | 120.7 | 24.8 | 386.7% |
| Group's net profit margin after MI | 5.9% | 1.3% | +466 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2018 | 31.12.2017 | % change |
| Total assets | 4,852.9 | 5,061.4 | -4.1% |
| Shareholders' equity | 2,915.9 | 2,860.1 | 2.0% |
| Minority interests | 38.1 | 36.7 | 3.9% |
| Cash and cash equivalents | 211.1 | 362.1 | -41.7% |
| Financial debt | 1,069.0 | 1,271.1 | -15.9% |
| Net debt | 857.9 | 909.1 | -5.6% |
| Podravka Group's cash flow (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
| Net cash flow from operating activities | 99.0 | 136.7 | -27.6% |
| Capital expenditures | 67.4 | 122.9 | -45.2% |
| Depreciation and amortization | 94.3 | 95.2 | -0.9% |
| Free cash flow | 31.6 | 13.8 | 128.9% |
| Podravka Group's ratios and indicators | 30.06.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,531 | 6,306 | 3.6% |
| P&L interest expense (in HRKm) | 23.4 | 26.9 | -13.0% |
| Sales revenues / Number of employees (in HRK000) | 642.3 | 651.9 | -1.5% |
| Net profit after MI / Sales revenues (in HRK000) | 17.5 | 2.9 | 503.8% |
| Return on average assets | 2.4% | 0.5% | +190 bp |
| Return on average capital | 4.0% | 0.8% | +318 bp |
| Return on average invested capital | 4.2% | 1.9% | +229 bp |
| Total shareholders' equity / Total assets | 60.9% | 57.2% | +364 bp |
| EBIT / P&L interest expense | 8.4 | 3.4 | 146.7% |
| Net debt / EBITDA | 1.8 | 2.4 | -26.1% |
| Sales (in HRKm) | 1-3 2018 | 1-3 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 987.1 | 919.5 | 7.3% |
| Sales revenues of Podravka Group | 988.9 | 913.2 | 8.3% |
| Sales revenues of Food | 789.8 | 723.6 | 9.2% |
| Sales revenues of Pharma | 199.0 | 189.6 | 5.0% |
| Podravka Group's profitability (in HRKm) | 1-3 2018 | 1-3 2017 | % change |
| Group's gross profit | 372.2 | 325.3 | 14.4% |
| Group's gross profit margin | 37.6% | 35.6% | +201 bp |
| Group's EBITDA | 135.6 | 75.8 | 78.9% |
| Group's EBITDA margin | 13.7% | 8.3% | +541 bp |
| Group's EBIT | 87.7 | 28.2 | 210.7% |
| Group's EBIT margin | 8.9% | 3.1% | +578 bp |
| Group's net profit after MI | 69.8 | 18.0 | 287.3% |
| Group's net profit margin after MI | 7.1% | 2.0% | +509 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2018 | 31.12.2017 | % change |
| Total assets | 4,902.4 | 5,061.4 | -3.1% |
| Shareholders' equity | 2,921.8 | 2,860.1 | 2.2% |
| Minority interests | 37.9 | 36.7 | 3.3% |
| Cash and cash equivalents | 195.8 | 362.1 | -45.9% |
| Financial debt | 1,161.3 | 1,271.1 | -8.6% |
| Net debt | 965.5 | 909.1 | 6.2% |
| Podravka Group's cash flow (in HRKm) | 1-3 2018 | 1-3 2017 | % change |
| Net cash flow from operating activities | (41.4) | 48.1 | -186.0% |
| Capital expenditures | 24.5 | 84.7 | -71.1% |
| Depreciation and amortization | 47.9 | 47.6 | 0.7% |
| Free cash flow | (65.9) | (36.6) | 80.2% |
| Podravka Group's ratios and indicators | 31.03.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,407 | 6,306 | 1.6% |
| P&L interest expense (in HRKm) | 25.0 | 26.9 | -7.0% |
| Sales revenues / Number of employees (in HRK000) | 653.5 | 651.9 | 0.2% |
| Net profit after MI / Sales revenues (in HRK000) | 10.9 | 2.9 | 277.7% |
| Return on average assets | 1.5% | 0.5% | +102 bp |
| Return on average capital | 2.5% | 0.8% | +170 bp |
| Return on average invested capital | 3.2% | 1.9% | +127 bp |
| Total shareholders' equity / Total assets | 60.4% | 57.2% | +314 bp |
| EBIT / P&L interest expense | 6.0 | 3.4 | 77.4% |
| Net debt / EBITDA | 2.2 | 2.4 | -8.4% |
| Sales (in HRKm) | 1-12 2017 | 1-12 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,110.9 | 4,226.5 | -2.7% |
| Sales revenues of Podravka Group | 4,111.2 | 4,185.5 | -1.8% |
| Sales revenues of Food | 3,243.7 | 3,370.3 | -3.8% |
| Sales revenues of Pharma | 867.5 | 815.2 | 6.4% |
| Podravka Group's profitability (in HRKm) | 1-12 2017 | 1-12 2016 | % change |
| Group's gross profit | 1,484.1 | 1,535.2 | -3.3% |
| Group's gross profit margin | 36.1% | 36.7% | -58 bp |
| Group's EBITDA | 374.1 | 471.3 | -20.6% |
| Group's EBITDA margin | 9.1% | 11.3% | -216 bp |
| Group's EBIT | 91.1 | 268.9 | -66.1% |
| Group's EBIT margin | 2.2% | 6.4% | -421 bp |
| Group's net profit after MI | 18.2 | 182.4 | -90.0% |
| Group's net profit margin after MI | 0.4% | 4.4% | -391 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2017 | 31.12.2016 | % change |
| Total assets | 5,061.4 | 5,285.7 | -4.2% |
| Shareholders' equity | 2,860.1 | 2,877.2 | -0.6% |
| Minority interests | 36.7 | 49.2 | -25.5% |
| Cash and cash equivalents | 362.1 | 337.6 | 7.2% |
| Financial debt | 1,271.1 | 1,379.4 | -7.8% |
| Net debt | 909.1 | 1,041.7 | -12.7% |
| Podravka Group's cash flow (in HRKm) | 1-12 2017 | 1-12 2016 | % change |
| Net cash flow from operating activities | 473.4 | 476.7 | -0.7% |
| Capital expenditures | 206.8 | 437.1 | -52.7% |
| Depreciation and amortization | 194.0 | 191.4 | 1.4% |
| Free cash flow | 250.8 | 39.6 | 533.0% |
| Podravka Group's ratios and indicators | 2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,306 | 6,404 | -1.5% |
| P&L interest expense (in HRKm) | 26.9 | 31.5 | -14.6% |
| Sales revenues / Number of employees (in HRK000) | 651.9 | 653.6 | -0.2% |
| Net profit after MI / Sales revenues (in HRK000) | 2.9 | 28.5 | -89.8% |
| Return on average assets | 0.5% | 3.7% | -321 bp |
| Return on average capital | 0.8% | 6.5% | -572 bp |
| Return on average invested capital | 1.9% | 5.7% | -380 bp |
| Total shareholders' equity / Total assets | 57.2% | 55.4% | +187 bp |
| EBIT / P&L interest expense | 3.4 | 8.5 | -60.3% |
| Net debt / EBITDA | 2.4 | 2.2 | 9.9% |
| Sales (in HRKm) | 1-9 2017 | 1-9 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,979.5 | 3,049.4 | -2.3% |
| Sales revenues of Podravka Group | 2,983.1 | 3,030.8 | -1.6% |
| Sales revenues of Food | 2,372.4 | 2,465.2 | -3.8% |
| Sales revenues of Pharma | 610.7 | 565.6 | 8.0% |
| Podravka Group's profitability (in HRKm) | 1-9 2017 | 1-9 2016 | % change |
| Group's gross profit | 1,059.4 | 1,104.1 | -4.0% |
| Group's gross profit margin | 35.5% | 36.4% | -91 bp |
| Group's EBITDA | 254.4 | 337.4 | -24.6% |
| Group's EBITDA margin | 8.5% | 11.1% | -260 bp |
| Group's EBIT | 110.5 | 201.2 | -45.1% |
| Group's EBIT margin | 3.7% | 6.6% | -293 bp |
| Group's net profit after MI | 54.1 | 142.2 | -62.0% |
| Group's net profit margin after MI | 1.8% | 4.7% | -288 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2017 | 31.12.2016 | % change |
| Total assets | 5,072.9 | 5,285.7 | -4.0% |
| Shareholders' equity | 2,890.2 | 2,877.2 | 0.5% |
| Minority interests | 36.3 | 49.2 | -26.2% |
| Cash and cash equivalents | 178.6 | 337.6 | -47.1% |
| Financial debt | 1,326.4 | 1,379.4 | -3.8% |
| Net debt | 1,147.8 | 1,041.7 | 10.2% |
| Podravka Group's cash flow (in HRKm) | 1-9 2017 | 1-9 2016 | % change |
| Net cash flow from operating activities | 193.1 | 299.3 | -35.5% |
| Capital expenditures | 158.8 | 383.7 | -58.6% |
| Depreciation and amortization | 143.8 | 136.1 | 5.7% |
| Free cash flow | 34.3 | -84.4 | n/p |
| Podravka Group's ratios and indicators | 30.09.2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,620 | 6,404 | 3.4% |
| P&L interest expense (in HRKm) | 26.8 | 31.5 | -15.0% |
| Sales revenues / Number of employees (in HRK000) | 625.0 | 653.6 | -4.4% |
| Net profit after MI / Sales revenues (in HRK000) | 14.2 | 28.5 | -50.0% |
| Return on average assets | 1.9% | 3.7% | -173 bp |
| Return on average capital | 3.4% | 6.5% | -310 bp |
| Return on average invested capital | 3.6% | 5.7% | -213 bp |
| Total shareholders' equity / Total assets | 57.7% | 55.4% | +232 bp |
| EBIT / P&L interest expense | 6.7 | 8.5 | -22.1% |
| Net debt / EBITDA | 3.0 | 2.2 | 33.8% |
| Sales (in HRKm) | 1-6 2017 | 1-6 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,955.3 | 1,998.4 | -2.2% |
| Sales revenues of Podravka Group | 1,951.2 | 1,988.5 | -1.9% |
| Sales revenues of Food | 1,544.4 | 1,609.5 | -4.0% |
| Sales revenues of Pharma | 406.8 | 379.1 | 7.3% |
| Podravka Group's profitability (in HRKm) | 1-6 2017 | 1-6 2016 | % change |
| Group's gross profit | 689.3 | 723.8 | -4.8% |
| Group's gross profit margin | 35.3% | 36.4% | -107 bp |
| Group's EBITDA | 140.0 | 222.0 | -36.9% |
| Group's EBITDA margin | 7.2% | 11.2% | -399 bp |
| Group's EBIT | 44.8 | 129.8 | -65.5% |
| Group's EBIT margin | 2.3% | 6.5% | -423 bp |
| Group's net profit after MI | 24.8 | 97.3 | -74.5% |
| Group's net profit margin after MI | 1.3% | 4.9% | -362 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2017 | 31.12.2016 | % change |
| Total assets | 5,112.1 | 5,285.7 | -3.3% |
| Shareholders' equity | 2,895.6 | 2,877.2 | 0.6% |
| Minority interests | 51.1 | 49.2 | 3.9% |
| Cash and cash equivalents | 285.8 | 337.6 | -15.3% |
| Financial debt | 1,370.2 | 1,379.4 | -0.7% |
| Net debt | 1,084.4 | 1,041.7 | 4.1% |
| Podravka Group's cash flow (in HRKm) | 1-6 2017 | 1-6 2016 | % change |
| Net cash flow from operating activities | 136.7 | 142.0 | -3.7% |
| Capital expenditures | 122.9 | 233.1 | -47.3% |
| Depreciation and amortization | 95.2 | 92.2 | 3.2% |
| Free cash flow | 13.8 | -91.1 | n/a |
| Podravka Group's ratios and indicators | 30.06.2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,432 | 6,404 | 0.4% |
| P&L interest expense (in HRKm) | 27.7 | 31.5 | -11.9% |
| Sales revenues / Number of employees (in HRK000) | 644.9 | 653.6 | -1.3% |
| Net profit after MI / Sales revenues (in HRK000) | 17.1 | 28.5 | -40.0% |
| Return on average assets | 2.3% | 3.7% | -142 bp |
| Return on average capital | 4.0% | 6.5% | -255 bp |
| Return on average invested capital | 3.8% | 5.7% | -195 bp |
| Total shareholders' equity / Total assets | 57.6% | 55.4% | +228 bp |
| EBIT / P&L interest expense | 6.6 | 8.5 | -22.3% |
| Net debt / EBITDA | 2.8 | 2.2 | 26.1% |
| Sales (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 915.5 | 1,002.9 | -8.7% |
| Sales revenues of Podravka Group | 913.2 | 997.1 | -8.4% |
| Sales revenues of Food | 723.6 | 814.6 | -11.2% |
| Sales revenues of Pharma | 189.6 | 182.5 | 3.9% |
| Podravka Group's profitability (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
| Group's gross profit | 320.6 | 365.5 | -12.3% |
| Group's gross profit margin | 35.1% | 36.7% | -154 bp |
| Group's EBITDA | 75.8 | 126.9 | -40.3% |
| Group's EBITDA margin | 8.3% | 12.7% | -442 bp |
| Group's EBIT | 28.2 | 81.1 | -65.2% |
| Group's EBIT margin | 3.1% | 8.1% | -504 bp |
| Group's net profit after MI | 18.0 | 60.1 | -70.0% |
| Group's net profit margin after MI | 2.0% | 6.0% | -405 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2017 | 31.12.2016 | % change |
| Total assets | 5,182.2 | 5,285.7 | -2.0% |
| Shareholders' equity | 2,890.0 | 2,877.2 | 0.4% |
| Minority interests | 50.2 | 49.2 | 2.0% |
| Cash and cash equivalents | 250.5 | 337.6 | -25.8% |
| Financial debt | 1,338.1 | 1,379.4 | -3.0% |
| Net debt | 1,087.6 | 1,041.7 | 4.4% |
| Podravka Group's cash flow (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
| Net cash flow from operating activities | 48.1 | -5.0 | n/a |
| Capital expenditures | 84.7 | 121.1 | -30.0% |
| Depreciation and amortization | 47.6 | 45.8 | 3.9% |
| Free cash flow | -36.6 | -126.0 | -71.0% |
| Podravka Group's ratios and indicators | 31.03.2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,497 | 6,404 | 1.5% |
| P&L interest expense (in HRKm) | 29.4 | 31.5 | -6.5% |
| Sales revenues / Number of employees (in HRK000) | 631.3 | 653.6 | -3.4% |
| Net profit after MI / Sales revenues (in HRK000) | 21.6 | 28.5 | -24.2% |
| Return on average assets | 2.8% | 3.7% | -83 bp |
| Return on average capital | 5.0% | 6.5% | -150 bp |
| Return on average invested capital | 4.4% | 5.7% | -129 bp |
| Total shareholders' equity / Total assets | 56.7% | 55.4% | +137 bp |
| EBIT / P&L interest expense | 7.3 | 8.5 | -14.1% |
| Net debt / EBITDA | 2.6 | 2.2 | 17.1% |
| Sales (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,226.5 | 3,761.1 | 12.4% |
| Sales revenues of Podravka Group | 4,185.5 | 3,626.8 | 15.4% |
| Sales revenues of Food | 3,370.3 | 2,821.8 | 19.4% |
| Sales revenues of Pharma | 815.2 | 805.0 | 1.3% |
| Podravka Group's profitability (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
| Group's gross profit | 1,518.9 | 1,385.1 | 9.7% |
| Group's gross profit margin | 36.3% | 38.2% | -190 bp |
| Group's EBITDA | 469.6 | 468.6 | 0.2% |
| Group's EBITDA margin | 11.2% | 12.9% | -170 bp |
| Group's EBIT | 268.9 | 285.2 | -5.7% |
| Group's EBIT margin | 6.4% | 7.9% | -144 bp |
| Group's net profit after MI | 182.4 | 397.3 | -54.1% |
| Group's net profit margin after MI | 4.4% | 11.0% | -660 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2016 | 31.12.2015 | % change |
| Total assets | 5,285.7 | 4,991.6 | 5.9% |
| Shareholders' equity | 2,877.2 | 2,750.0 | 4.6% |
| Minority interests | 49.2 | 67.7 | -27.3% |
| Cash and cash equivalents | 337.6 | 291.9 | 15.7% |
| Financial debt | 1,379.4 | 1,214.3 | 13.6% |
| Net debt | 1,041.7 | 922.4 | 12.9% |
| Podravka Group's cash flow (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
| Net cash flow from operating activities | 476.7 | 274.2 | 73.8% |
| Capital expenditures | 437.1 | 271.2 | 61.2% |
| Depreciation and amortization | 191.4 | 148.3 | 29.1% |
| Free cash flow | 39.6 | 3.0 | 1226.2% |
| Podravka Group's ratios and indicators | 2016 | 2015 | % change |
| Employee number at the end of period (in units) | 6,404 | 6,657 | -3.8% |
| P&L interest expense (in HRKm) | 31.5 | 36.9 | -14.8% |
| Sales revenues / Number of employees (in HRK000) | 653.6 | 544.8 | 20.0% |
| Net profit after MI / Sales revenues (in HRK000) | 28.5 | 59.7 | -52.3% |
| Return on average assets | 3.7% | 9.5% | -583 bp |
| Return on average capital | 6.5% | 17.5% | -1098 bp |
| Return on average invested capital | 5.7% | 8.9% | -322 bp |
| Total shareholders' equity / Total assets | 55.4% | 56.5% | -109 bp |
| EBIT / P&L interest expense | 8.5 | 7.7 | 10.6% |
| Net debt / EBITDA | 2.2 | 2.0 | 10.9% |
| Sales (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,044.3 | 2,503.6 | 21.6% |
| Sales revenues of Podravka Group | 3,030.8 | 2,462.2 | 23.1% |
| Sales revenues of Food | 2,465.2 | 1,897.8 | 29.9% |
| Sales revenues of Pharma | 565.7 | 564.3 | 0.2% |
| Podravka Group's profitability (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
| Group's gross profit | 1,104.1 | 957.2 | 15.3% |
| Group's gross profit margin | 36.4% | 38.9% | -245 bp |
| Group's EBITDA | 337.4 | 276.5 | 22.0% |
| Group's EBITDA margin | 11.1% | 11.2% | -10 bp |
| Group's EBIT | 201.2 | 166.8 | 20.6% |
| Group's EBIT margin | 6.6% | 6.8% | -14 bp |
| Group's net profit after MI | 142.2 | 131.0 | 8.6% |
| Group's net profit margin after MI | 4.7% | 5.3% | -63 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2016 | 31.12.2015 | % change |
| Total assets | 5,082.4 | 4,945.8 | 2.8% |
| Shareholders' equity | 2,828.3 | 2,750.0 | 2.8% |
| Minority interests | 48.2 | 67.7 | -28.8% |
| Cash and cash equivalents | 219.4 | 291.9 | -24.8% |
| Financial debt | 1,375.0 | 1,214.3 | 13.2% |
| Net debt | 1,155.6 | 922.4 | 25.3% |
| Podravka Group's cash flow (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
| Net cash flow from operating activities | 299.3 | 32.3 | 826.9% |
| Capital expenditures | 383.7 | 144.7 | 165.2% |
| Depreciation and amortization | 136.1 | 101.2 | 34.5% |
| Free cash flow | (84.4) | (112.4) | -24.9% |
| Podravka Group's ratios and indicators | 1-9 2016. | 2015 | % change |
| Employee number at the end of period (in units) | 6,754 | 6,657 | 1.5% |
| P&L interest expense (in HRKm) | 35.0 | 36.9 | -5.2% |
| Sales revenues / Number of employees (in HRK000) | 621.2 | 544.8 | 14.0% |
| Net profit after MI / Sales revenues (in HRK000) | 60.5 | 59.7 | 1.3% |
| Return on average assets | 8.4% | 9.5% | -114 bp |
| Return on average capital | 14.7% | 17.5% | -281 bp |
| Return on average invested capital | 8.8% | 8.9% | -10 bp |
| Total shareholders' equity / Total assets | 56.6% | 56.5% | -38 bp |
| EBIT / P&L interest expense | 9.1 | 7.7 | 18.3% |
| Net debt / EBITDA | 2.2 | 2.0 | 10.9% |
| Sales (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,998.4 | 1,613.7 | 23.8% |
| Sales revenues of Podravka Group | 1,988.5 | 1,576.3 | 26.2% |
| Sales revenues of Food | 1,609.5 | 1,198.7 | 34.3% |
| Sales revenues of Pharma | 379.1 | 377.6 | 0.4% |
| Podravka Group's profitability (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
| Group's gross profit | 723.8 | 614.3 | 17.8% |
| Group's gross profit margin | 36.4% | 39.0% | -257 bp |
| Group's EBITDA | 222.0 | 196.1 | 13.2% |
| Group's EBITDA margin | 11.2% | 12.4% | -128 bp |
| Group's EBIT | 129.8 | 123.2 | 5.4% |
| Group's EBIT margin | 6.5% | 7.8% | -129 bp |
| Group's net profit after MI | 97.3 | 91.9 | 5.8% |
| Group's net profit margin after MI | 4.9% | 5.8% | -94 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2016 | 31.12.2015 | % change |
| Total assets | 4,947.9 | 4,945.8 | 0.0% |
| Shareholders' equity | 2,835.3 | 2,750.0 | 3.1% |
| Minority interests | 46.6 | 67.7 | -31.2% |
| Cash and cash equivalents | 242.2 | 291.9 | -17.0% |
| Financial debt | 1,264.3 | 1,214.3 | 4.1% |
| Net debt | 1,022.1 | 922.4 | 10.8% |
| Podravka Group's cash flow (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
| Net cash flow from operating activities | 142.0 | (11.9) | n/a |
| Capital expenditures | 233.1 | 60.6 | 284.7% |
| Depreciation and amortization | 92.2 | 67.3 | 36.9% |
| Free cash flow | (91.1) | (72.5) | 25.6% |
| Podravka Group's ratios and indicators | 1-6 2016 | 2015 | % change |
| Employee number at the end of period (in units) | 6,672 | 6,657 | 0.2% |
| P&L interest expense (in HRKm) | 35.6 | 36.9 | -3.6% |
| Sales revenues / Number of employees (in HRK000) | 605.4 | 544.8 | 11.1% |
| Net profit after MI / Sales revenues (in HRK000) | 60.4 | 59.7 | 1.1% |
| Return on average assets | 8.3% | 9.5% | -115 bp |
| Return on average capital | 14.5% | 17.5% | -306 bp |
| Return on average invested capital | 7.6% | 8.9% | -130 bp |
| Total shareholders' equity / Total assets | 58.2% | 56.5% | +127 bp |
| EBIT / P&L interest expense | 8.1 | 7.7 | 4.4% |
| Net debt / EBITDA | 2.1 | 2.0 | 5.0% |
Notes:
Possible decimal differences due to rounding.
Financial debt = Non-current and current borrowings + Financial liabilities at fair value through profit and loss.
Net debt = Financial debt - Cash and cash equivalents.
Free cash flow = Net cash flow from operating activities - Capital expenditures.
Return on average assets = Net profit / Average total assets.
Return on average equity = Net profit / Average total shareholders' equity.
Return on average invested capital = EBIT*0.82 / (Average total shareholders' equity + average financial debt - average cash and cash equivalents).
Ratios and indicators have been calculated on the TTM basis.
